Avadel Pharmaceuticals (AVDL) News Today → Wall Street Legend Warns: 'A Strange Day Is Coming to America' (From Chaikin Analytics) (Ad) Free AVDL Stock Alerts $15.49 -0.26 (-1.65%) (As of 05/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 22, 2024 | finanznachrichten.deAvadel Pharmaceuticals plc: Avadel Pharmaceuticals Shares New LUMRYZ (sodium oxybate) For Extended-release Oral Suspension (CIII) Data at SLEEP 2024May 22, 2024 | finance.yahoo.comAvadel Pharmaceuticals Shares New LUMRYZ™ (sodium oxybate) For Extended-release Oral Suspension (CIII) Data at SLEEP 2024May 22, 2024 | globenewswire.comAvadel Pharmaceuticals Shares New LUMRYZ™ (sodium oxybate) For Extended-release Oral Suspension (CIII) Data at SLEEP 2024May 21, 2024 | globenewswire.comAvadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of DirectorsMay 20, 2024 | marketbeat.comBrandes Investment Partners LP Has $21.66 Million Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL)Brandes Investment Partners LP boosted its holdings in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 5.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,533,614 shares of thMay 16, 2024 | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Receives Consensus Rating of "Buy" from AnalystsAvadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) has received a consensus rating of "Buy" from the six research firms that are covering the firm, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average 12 month price target among broMay 13, 2024 | msn.comAvadel gains for a second day as analysts see it prevailing in case vs Jazz/FDAMay 11, 2024 | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Sees Significant Decrease in Short InterestAvadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) was the target of a large decrease in short interest in April. As of April 30th, there was short interest totalling 4,800,000 shares, a decrease of 54.8% from the April 15th total of 10,610,000 shares. Based on an average trading volume of 1,250,000 shares, the days-to-cover ratio is currently 3.8 days.May 10, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Trading 5.2% Higher on Analyst UpgradeAvadel Pharmaceuticals (NASDAQ:AVDL) Stock Price Up 5.2% on Analyst UpgradeMay 10, 2024 | marketbeat.comQ4 2024 EPS Estimates for Avadel Pharmaceuticals plc (NASDAQ:AVDL) Reduced by Leerink PartnrsAvadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) - Investment analysts at Leerink Partnrs decreased their Q4 2024 earnings per share (EPS) estimates for shares of Avadel Pharmaceuticals in a report issued on Wednesday, May 8th. Leerink Partnrs analyst M. Goodman now expects that the companyMay 10, 2024 | markets.businessinsider.comBuy Rating Affirmed for Avadel Pharmaceuticals Amidst Strong Growth Potential and Market ExpansionMay 9, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Price Target Raised to $27.00HC Wainwright lifted their target price on shares of Avadel Pharmaceuticals from $25.00 to $27.00 and gave the company a "buy" rating in a research note on Thursday.May 9, 2024 | finance.yahoo.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Q1 2024 Earnings Call TranscriptMay 9, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Issues Earnings ResultsAvadel Pharmaceuticals (NASDAQ:AVDL - Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.30) earnings per share for the quarter, missing the consensus estimate of ($0.25) by ($0.05). The business had revenue of $27.18 million for the quarter, compared to analyst estimates of $25.89 million. The company's revenue for the quarter was up 2617.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.48) EPS.May 9, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Shares Down 7.3% on Disappointing EarningsAvadel Pharmaceuticals (NASDAQ:AVDL) Shares Down 7.3% on Disappointing EarningsMay 8, 2024 | msn.comAvadel Pharmaceuticals GAAP EPS of -$0.30 misses by $0.29, revenue of $27.18M beats by $1.28MMay 8, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Down to $18.18Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Down to $18.18May 8, 2024 | investorplace.comAVDL Stock Earnings: Avadel Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024May 8, 2024 | finanznachrichten.deAvadel Pharmaceuticals plc: Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial ResultsMay 8, 2024 | finance.yahoo.comAvadel Pharmaceuticals Reports First Quarter 2024 Earnings: Revenue Surpasses Estimates but Net ...May 8, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Receives Buy Rating from Needham & Company LLCNeedham & Company LLC reiterated a "buy" rating and set a $22.00 price objective on shares of Avadel Pharmaceuticals in a research note on Wednesday.May 8, 2024 | globenewswire.comAvadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial ResultsMay 2, 2024 | marketbeat.comAvadel Pharmaceuticals (AVDL) to Release Quarterly Earnings on WednesdayAvadel Pharmaceuticals (NASDAQ:AVDL) will be releasing earnings before the market opens on Wednesday, May 8, Zacks reports.May 1, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Reaches New 1-Year High at $18.97Avadel Pharmaceuticals (NASDAQ:AVDL) Sets New 12-Month High at $18.97May 1, 2024 | globenewswire.comAvadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 8April 29, 2024 | finance.yahoo.comWall Street Analysts Predict a 28.58% Upside in Avadel (AVDL): Here's What You Should KnowApril 27, 2024 | marketbeat.comVivo Capital LLC Sells 124,329 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL)Vivo Capital LLC reduced its stake in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 3.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,972,099 shares of the company's stock aftApril 25, 2024 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday TradingApril 21, 2024 | money.usnews.comAvadel Pharmaceuticals plcApril 18, 2024 | marketbeat.com106,475 Shares in Avadel Pharmaceuticals plc (NASDAQ:AVDL) Purchased by Investors Asset Management of Georgia Inc. GA ADVInvestors Asset Management of Georgia Inc. GA ADV acquired a new position in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 106,April 17, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Shares Down 3.4% Avadel Pharmaceuticals (NASDAQ:AVDL) Stock Price Down 3.4%April 16, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Hits New 1-Year High at $18.08Avadel Pharmaceuticals (NASDAQ:AVDL) Reaches New 12-Month High at $18.08April 16, 2024 | marketbeat.comAvadel Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:AVDL)Avadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) saw unusually large options trading activity on Tuesday. Stock traders purchased 4,733 call options on the company. This represents an increase of approximately 92% compared to the typical volume of 2,463 call options.April 16, 2024 | finance.yahoo.comAvadel Pharmaceuticals plc (AVDL)April 15, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Trading 5.9% Higher Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Up 5.9%April 11, 2024 | marketbeat.comTraders Buy Large Volume of Put Options on Avadel Pharmaceuticals (NASDAQ:AVDL)Avadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) saw some unusual options trading activity on Thursday. Traders bought 3,934 put options on the company. This is an increase of 73% compared to the average daily volume of 2,276 put options.April 11, 2024 | finance.yahoo.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Is Expected To Breakeven In The Near FutureApril 9, 2024 | marketbeat.comAvadel Pharmaceuticals' (AVDL) "Buy" Rating Reiterated at Needham & Company LLCNeedham & Company LLC reissued a "buy" rating and issued a $22.00 price objective on shares of Avadel Pharmaceuticals in a research report on Tuesday.April 4, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Share Price Passes Above 200-Day Moving Average of $13.24Avadel Pharmaceuticals (NASDAQ:AVDL) Stock Crosses Above 200-Day Moving Average of $13.24April 2, 2024 | seekingalpha.comAvadel Pharmaceuticals: A Deep Dive Into Lumryz's Once-Nightly RevolutionApril 1, 2024 | globenewswire.comAvadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare ConferenceMarch 17, 2024 | finance.yahoo.comAVDL Apr 2024 15.000 callMarch 16, 2024 | finance.yahoo.comAVDL Apr 2024 25.000 callMarch 16, 2024 | finance.yahoo.comAVDL Apr 2024 10.000 putMarch 15, 2024 | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Sees Significant Growth in Short InterestAvadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) was the recipient of a large increase in short interest in February. As of February 29th, there was short interest totalling 10,740,000 shares, an increase of 21.2% from the February 14th total of 8,860,000 shares. Based on an average daily volume of 1,270,000 shares, the days-to-cover ratio is currently 8.5 days.March 8, 2024 | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Shares Sold by Adage Capital Partners GP L.L.C.Adage Capital Partners GP L.L.C. trimmed its stake in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 35.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,725,000 shares of the company's stock aftMarch 7, 2024 | markets.businessinsider.comBuy Rating Affirmed for Avadel Pharmaceuticals Amid Strong Q4 Performance and Promising Growth ProspectsMarch 7, 2024 | marketbeat.comKennedy Capital Management LLC Acquires 268,704 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL)Kennedy Capital Management LLC boosted its position in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 60.2% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 715,424 shares of theMarch 7, 2024 | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Forecasted to Earn FY2024 Earnings of ($1.02) Per ShareAvadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) - Investment analysts at Lifesci Capital issued their FY2024 earnings per share (EPS) estimates for shares of Avadel Pharmaceuticals in a report released on Monday, March 4th. Lifesci Capital analyst M. Belghiti forecasts that the company wilMarch 6, 2024 | marketbeat.comRTW Investments LP Acquires 325,774 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL)RTW Investments LP lifted its holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 4.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,136,415 shares of the company's stock after purchasing an Get Avadel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter. Email Address Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad)Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble. Click here if you’d like to learn more about these five cryptos… AVDL Media Mentions By Week AVDL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVDL News Sentiment▼0.560.91▲Average Medical News Sentiment AVDL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVDL Articles This Week▼62▲AVDL Articles Average Week Get Avadel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: COLL News Today BCYC News Today IMUX News Today AGLE News Today IONS News Today OGN News Today BBIO News Today CYTK News Today APLS News Today MDGL News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AVDL) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesElon’s New Device is About to Shock the WorldInvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for AIWeiss RatingsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDigitizing the $11T commodities sector with one tiny stockResource Stock DigestMusk, Bezos, and Gates All On Board… Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avadel Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
